Physician profile
Sarah Kahn
NPI 1043385743
$4,859.14
in general payments reported to CMS, 2019-2025
25 companies · $950 in 2025
The $950 reported for 2025 was more than what a typical Gastroenterology (Internal Medicine) provider received nationally (typical 2025 total: $636).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $853 · 2020: $783 · 2021: $764 · 2022: $422 · 2023: $590 · 2024: $497 · 2025: $950.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,037.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,037.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,520.27 | 2019-2025 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $1,021.30 | 2019-2024 | Xifaxan |
| Pfizer INC. | $457.59 | 2019-2025 | |
| Gilead Sciences, INC. | $279.04 | 2019-2025 | |
| Ardelyx, INC. | $179.00 | 2024-2025 | Ibsrela |
| Boston Scientific Corporation | $146.78 | 2023-2024 | Cre Pro |
| Qol Medical, LLC | $128.54 | 2020-2025 | Sucraid |
| Takeda Pharmaceuticals U.S.A., INC. | $127.15 | 2019-2021 | |
| Ethicon US, LLC | $120.42 | 2019 | |
| Allergan, INC. | $112.23 | 2019-2020 | |
| Janssen Biotech, INC. | $107.78 | 2019-2024 | Simponi, Tremfya, Simponi Aria |
| Celgene Corporation | $86.65 | 2022-2023 | Zeposia |
| Cook Medical LLC | $83.38 | 2022 | |
| Nestle Healthcare Nutrition INC. | $80.26 | 2021 | |
| Redhill Biopharma INC. | $77.81 | 2020-2023 | Movantik, Talicia, Aemcolo |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $69.62 | 2019-2021 | |
| Ironwood Pharmaceuticals, INC | $68.24 | 2020-2021 | |
| Abbott Laboratories | $48.76 | 2023 | Cardiomems |
| Endogastric Solutions, INC | $35.63 | 2019 | |
| Ipsen Biopharmaceuticals, INC | $27.42 | 2025 | Iqirvo |
| Novo Nordisk INC | $24.39 | 2025 | Wegovy |
| Exact Sciences Corporation | $19.80 | 2023 | Cologuard Collection Kit |
| Medtronic Vascular, INC. | $13.32 | 2020 | |
| Intercept Pharmaceuticals, INC. | $12.01 | 2020 | |
| Ferring Pharmaceuticals INC. | $11.75 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sarah Kahn listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.